相似文献
1
Importance of Life-Long Alerts in Electronic Medical Report Systems for Patients With Positive Antigen Screening.
Cureus. 2022 Feb 24;14(2):e22561. doi: 10.7759/cureus.22561. eCollection 2022 Feb.
2
Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Transfus Clin Biol. 2019 May;26(2):112-115. doi: 10.1016/j.tracli.2019.02.003. Epub 2019 Feb 22.
3
Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.
Hematol Transfus Cell Ther. 2018 Oct-Dec;40(4):326-331. doi: 10.1016/j.htct.2018.04.001. Epub 2018 May 22.
4
Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
J Clin Apher. 2017 Feb;32(1):59-61. doi: 10.1002/jca.21461. Epub 2016 Apr 26.
5
Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
BMC Surg. 2017 Apr 26;17(1):48. doi: 10.1186/s12893-017-0241-y.
6
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Transfusion. 2002 Jan;42(1):37-43. doi: 10.1046/j.1537-2995.2002.00007.x.
7
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Transfus Med Rev. 2019 Jan;33(1):12-23. doi: 10.1016/j.tmrv.2018.07.003. Epub 2018 Jul 26.
8
Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
Mymensingh Med J. 2019 Apr;28(2):364-369.
9
Alloimmunization in transfused patients with constitutional anemias in Norway.
Transfus Apher Sci. 2021 Oct;60(5):103257. doi: 10.1016/j.transci.2021.103257. Epub 2021 Aug 17.
10
Red cell transfusion and alloimmunization in sickle cell disease.
Haematologica. 2021 Jul 1;106(7):1805-1815. doi: 10.3324/haematol.2020.270546.
本文引用的文献
1
To Win the Battle, First Know Your Enemy: Error Rates in Immunohematology External Quality Assessment Results.
Transfus Med Hemother. 2020 Feb;47(1):80-87. doi: 10.1159/000499941. Epub 2019 May 17.
2
Variability in blood and blood component utilization as assessed by an anesthesia information management system.
Anesthesiology. 2012 Jul;117(1):99-106. doi: 10.1097/ALN.0b013e318255e550.
3
Anti-U alloimmunisation in a pregnant woman from Niger.
Blood Transfus. 2012 Apr;10(2):221-4. doi: 10.2450/2012.0049-11. Epub 2012 Feb 13.
4
Operational, quality, and risk management in the transfusion service: lessons learned.
Transfus Med Rev. 2012 Jul;26(3):252-61. doi: 10.1016/j.tmrv.2011.10.002. Epub 2011 Dec 3.
5
Distribution and heredity of blood factor U.
Science. 1954 May 21;119(3099):734-5. doi: 10.1126/science.119.3099.734.
6
Type and screen completion for scheduled surgical procedures. A College of American Pathologists Q-Probes study of 8941 type and screen tests in 108 institutions.
Arch Pathol Lab Med. 2003 May;127(5):533-40. doi: 10.5858/2003-127-0533-TASCFS.
7
Transfusing patients with autoimmune haemolytic anaemia.
Lancet. 1993 May 8;341(8854):1220. doi: 10.1016/0140-6736(93)91056-r.
8
Delayed overt hemolytic transfusion reaction due to anti-U antibody.
Transfusion. 1976 Jul-Aug;16(4):357-60. doi: 10.1046/j.1537-2995.1976.16476247058.x.
Zotero 插件